| Name | Title | Contact Details |
|---|---|---|
Barry Silver |
Vice President of Technology Operations | Profile |
In July 2014, Genoa Healthcare and QoL meds combined to create Genoa, a QoL Healthcare Company, the nation`s leading behavioral health specialty pharmacy company. This merger brought together two pharmacy organizations with proven track records for excellent service to individuals with mental illness. Both companies had strong reputations for outstanding customer service, flexibility and delivering true value to their consumers and partners. By uniting their strengths – like best practices and expertise – the combined company was able to better serve individuals and the health organizations that care for them over the past year. Genoa has been serving the behavioral health community for over 15 years. The company now provides specialty behavioral health and long-term care pharmacy services to more than 500,000 individuals annually, operating over 285 pharmacies in 39 states and the District of Columbia and filling more than 9 million prescriptions per year. Although Genoa specializes in serving behavioral health consumers, we are a full-service pharmacy. This means we take care of all the medication needs of our consumers, including prescriptions written by psychiatrists, primary care providers, or other specialty prescribers. Genoa remains flexible to the many behavioral health and primary care delivery models across the country and developed services within our pharmacies to meet the needs of those specific models. None of our service models or pharmacies are the same. We take pride in not being a "cookie cutter" organization, and continue to seek opportunities nationwide to help behavioral health communities with their pharmacy services.
Headquartered in Waterloo, Iowa, VGM is a 100 percent employee-owned company providing business and professional services to thousands of business customers across North America. Services include group purchasing, commercial insurance, management of healthcare services and networks in post-acute cases, healthcare distribution direct to patient homes, specialty consulting, on-line education, digital, print and traditional marketing and more. VGM employs more than 1000 people across 30 states and Canada. Approximately 875 people work in the Waterloo offices and the remainder work in one of VGM`s eight offices outside of Waterloo or work from home. VGM has been named the Top Workplace in Iowa on multiple occasions and is proud of its role in the communities in which it serves.
Imwell Health is a Fort Smith, AR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
InfraReDx Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Burlington, MA. To find more information about InfraReDx Inc., please visit www.infraredx.com
Nivalis Therapeutics (formerly N30Pharma) is developing a novel class of disease modifying therapies that preserve intracellular GSNO (S-nitrosoglutathione), a key regulator of organ repair, regeneration, and healing. The Company’s lead program is focused on cystic fibrosis. As the body’s primary reservoir of nitric oxide (NO), GSNO plays a pivotal role in NO signaling. Decreased GSNO levels are associated with inflammatory lung disease, and with increased activity of GSNOR (GSNO reductase), the primary catabolizing enzyme of GSNO. Nivalis Therapeutics has developed a broad portfolio of proprietary, potent, small molecule inhibitors of GSNOR that have been shown to preserve endogenous GSNO levels and to be effective in “gold-standard” models of inflammatory lung disease. Nivalis Therapeutics is located in Boulder, Colorado.